News & Articles
Sherlock Biosciences announces clinical data from study of Sherlock CRISPR SARS-CoV-2 Kit
Data shows 100% concordance with results from Dartmouth-Hitchcock’s lab-based polymerase chain reaction (PCR) test method
Manchester experts’ breakthrough narrows intelligent life search in Milky Way
An analytical breakthrough that could significantly improve our chances of finding extra-terrestrial life in our galaxy
Teknova scales up production of viral transport media to support global response to COVID-19
Rapid increase in production of VTM and saline will help boost virus testing
New tool identifies which cancer patients are most likely to benefit from immunotherapy
A new prognostic tool developed by an international team led by CTI-Bath paves the way for personalized medicine for cancer patients
Fujitsu and Tokyo Shinagawa Hospital to develop an AI-based technology to support COVID-19 diagnosis
The new AI technology will learn from past CT scans of COVID-19 pneumonia patients, reducing the burden on doctors making diagnoses
FDA approves Roche's comprehensive pan-tumor liquid biopsy test for patients with solid tumors
FoundationOne Liquid CDx analyzes more than 300 cancer-related genes and multiple genomic signatures to inform treatment decisions for all solid tumor cancers
Thirona teams up with Smart Reporting to further improve COVID-19 detection
Combining image analysis with structured reporting, the software aims to improve and accelerate the detection of the virus
Colorcon Ventures invests in AI provider Atomwise for drug discovery Atomwise
Atomwise provides rapid and cost-effective compound screening to address pharmaceutical R&D productivity
SARS-CoV-2 rapid antigen test clinical collaboration
Avacta and Liverpool School of Tropical Medicine collaborate to clinically validate saliva-based rapid coronavirus test being developed with Cytiva
Fuel cells for hydrogen vehicles are becoming longer lasting
A University of Bern international research team has succeeded in developing an electrocatalyst for hydrogen fuel cells
Abbott's 15-minute, $5 COVID-19 antigen test receives FDA emergency use authorization
Test delivers results in just 15 minutes with no instrumentation, using proven lateral flow technology with demonstrated sensitivity of 97.1% and specificity of 98.5%
Phase I clinical trial initiated for monoclonal antibody combination for the prevention and treatment of COVID-19
First participants dosed in trial of AZD7442 to assess safety, tolerability and pharmacokinetics of the combination
Dotmatics announce the release of Bioregister 2020.1
Supports cross-functional teams of chemists and biologists developing non-natural, chemically modified therapeutics for drug discovery